The prognostic role of FDG PET/CT before combined radio-chemotherapy in anal cancer patients.

MLA

Leccisotti, Lucia, et al. “The Prognostic Role of FDG PET/CT before Combined Radio-Chemotherapy in Anal Cancer Patients.” Annals of Nuclear Medicine, vol. 34, no. 1, Jan. 2020, pp. 65–73. EBSCOhost, https://doi.org/10.1007/s12149-019-01416-y.

APA

Leccisotti, L., Manfrida, S., Barone, R., Ripani, D., Tagliaferri, L., Masiello, V., Privitera, V., Gambacorta, M. A., Rufini, V., Valentini, V., & Giordano, A. (2020). The prognostic role of FDG PET/CT before combined radio-chemotherapy in anal cancer patients. Annals of Nuclear Medicine, 34(1), 65–73. https://doi.org/10.1007/s12149-019-01416-y

Chicago

Leccisotti, Lucia, Stefania Manfrida, Roberto Barone, Daria Ripani, Luca Tagliaferri, Valeria Masiello, Vanessa Privitera, et al. 2020. “The Prognostic Role of FDG PET/CT before Combined Radio-Chemotherapy in Anal Cancer Patients.” Annals of Nuclear Medicine 34 (1): 65–73. doi:10.1007/s12149-019-01416-y.